According to a study conducted by M. Laé, 5.1% of invasive bladder carcinomas exhibited HER2 gene amplification, while HER2 overexpression was observed in 9.2% of tumor samples (Laé et al., 2010). The gene discussed is ERBB2; the disease is neoplasm.